YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

被引:0
|
作者
C. N. Rathcke
J. S. Johansen
H. Vestergaard
机构
[1] University of Copenhagen,Department of Endocrinology, Herlev Hospital
[2] University of Copenhagen,Department of Rheumatology, Herlev Hospital
来源
Inflammation Research | 2006年 / 55卷
关键词
Inflammation; Type 2 diabetes; YKL-40; CRP; Iinsulin resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Objective and design. YKL-40 participates in inflammatory states and vascular processes, which implies that comparison can be made with other inflammatory markers associated with insulin resistance and type 2 diabetes (T2D). In the present study levels of plasma YKL-40 and serum hsCRP were evaluated in patients with T2D.
引用
收藏
页码:53 / 59
页数:6
相关论文
共 50 条
  • [31] Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus
    Sakamoto, Fumie
    Katakami, Naoto
    Kaneto, Hideaki
    Yasuda, Tetsuyuki
    Takahara, Mitsuyoshi
    Miyashita, Kazuyuki
    Kuroda, Akio
    Matsuhisa, Munehide
    Kosugi, Keisuke
    Shimomura, Iichiro
    ENDOCRINE JOURNAL, 2013, 60 (01) : 73 - 79
  • [32] Plasma YKL-40 as a biomarker in patients with nonmetastatic bone and soft tissue sarcomas: a prospective exploratory clinical study
    Thorn, Andrea P.
    Harving, Mette L.
    Lausten, Gunnar S.
    Johansen, Julia S.
    Sorensen, Michala S.
    Petersen, Michael M.
    INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY, 2020, 5 (03):
  • [33] Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage
    Kacira, Tibet
    Hanimoglu, Hakan
    Kucur, Mine
    Sanus, Galip Zihni
    Kafadar, Ali Metin
    Tanriverdi, Taner
    Kaynar, Mehmet Yasar
    JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (09) : 1011 - 1016
  • [34] Association of Advanced Lipoprotein Subpopulation Profiles with Insulin Resistance and Inflammation in Patients with Type 2 Diabetes Mellitus
    Bakillah, Ahmed
    Obeid, Khamis Khamees
    Al Subaiee, Maram
    Soliman, Ayman Farouk
    Al Arab, Mohammad
    Bashir, Shahinaz Faisal
    Al Hussaini, Arwa
    Al Otaibi, Abeer
    Mubarak, Sindiyan Al Shaikh
    Iqbal, Jahangir
    Al Qarni, Ali Ahmed
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [35] YKL-40 levels in cerebrospinal fluid serve as a diagnostic biomarker for post-neurosurgical bacterial meningitis in patients with stroke
    Wang, Jingtao
    Wang, Xiaofeng
    Cheng, Hongwei
    Ye, Lei
    CLINICAL BIOCHEMISTRY, 2025, 135
  • [36] Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus
    Matsumoto, K
    Sera, Y
    Abe, Y
    Ueki, Y
    Tominaga, T
    Miyake, S
    ATHEROSCLEROSIS, 2003, 169 (02) : 317 - 321
  • [37] Resistin is Associated with Inflammation and Renal Function, but not with Insulin Resistance in Type 2 Diabetes
    Rzepa, Lukasz
    Peller, Michal
    Eyileten, Ceren
    Rosiak, Marek
    Kondracka, Agnieszka
    Mirowska-Guzel, Dagmara
    Opolski, Grzegorz
    Filipiak, Krzysztof J.
    Postula, Marek
    Kaplon-Cieslicka, Agnieszka
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (07) : 478 - 484
  • [38] Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
    Goldfine, Allison B.
    Silver, Robert
    Aldhahi, Waleed
    Cai, Dongsheng
    Tatro, Elizabeth
    Lee, Jongsoon
    Shoelson, Steven E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2008, 1 (01): : 36 - 43
  • [39] Diagnostic Performance of Biomarkers Urinary KIM-1 and YKL-40 for Early Diabetic Nephropathy, in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Kapoula, Georgia V.
    Kontou, Panagiota I.
    Bagos, Pantelis G.
    DIAGNOSTICS, 2020, 10 (11)
  • [40] Diagnostic role of circulating YKL-40 in endometrial carcinoma patients: a meta-analysis of seven related studies
    Cheng, Daye
    Sun, Ying
    He, Hu
    MEDICAL ONCOLOGY, 2014, 31 (12) : 1 - 6